ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,000 | +83900.0% | 3,270 | -6.6% | 0.07% | +6.2% |
| Q2 2023 | $100 | -1.0% | 3,500 | -16.7% | 0.06% | -9.7% |
| Q1 2023 | $101 | -99.9% | 4,200 | -35.5% | 0.07% | -10.0% |
| Q4 2022 | $110,494 | +64.9% | 6,515 | +44.1% | 0.08% | +53.8% |
| Q3 2022 | $67,000 | -9.5% | 4,520 | +8.9% | 0.05% | -5.5% |
| Q2 2022 | $74,000 | -31.5% | 4,150 | +3.8% | 0.06% | -17.9% |
| Q1 2022 | $108,000 | -5.3% | 4,000 | +29.4% | 0.07% | -9.5% |
| Q4 2021 | $114,000 | – | 3,090 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |